| Filed On | Filing |
|---|---|
| 17 Apr 2026 |
8-K/A: Other Events
On April 8, 2026, the Company issued a press release announcing (the “Public Announcement”) that it received Clinical Trial Notification acknowledgement from Australia’s Therapeutic Goods Administration and ethics approval from a Human R... |
| 07 Dec 2022 |
8-K/A: Departure/Election of Directors or Officers; Compensation
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS EXHIBIT MARKED BY [***] HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL |
| 01 Feb 2022 | 8-K/A: Submission of Matters to a Vote of Security Holders |
| 13 Oct 2020 | 8-K/A: Shareholder Director Nominations; Other Events |
| 19 Mar 2020 | 8-K/A: Other Events |
| 25 Feb 2020 | 8-K/A: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities |
Loading...
